RAPT Therapeutics, Inc. Accrued Liabilities, Current
RAPT Therapeutics, Inc. had Accrued Liabilities, Current of $9.01 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-11-06
- 2025-09-30: Accrued Liabilities, Current $9.01M.
- 2025-06-30: Accrued Liabilities, Current $6.58M.
- 2025-03-31: Accrued Liabilities, Current $4.93M.
- 2024-12-31: Accrued Liabilities, Current $9.60M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-09-30 | $9.01M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.58M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.93M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $9.60M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $6.40M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $9.49M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $11.81M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $14.10M 10-K · filed 2025-03-06 |
| 2023-09-30 | $14.11M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.29M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $10.35M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.66M 10-K · filed 2024-03-07 |
| 2022-09-30 | $8.24M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $7.51M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $8.28M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $6.33M 10-K · filed 2023-03-14 |
| 2021-09-30 | $6.84M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.07M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $4.54M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $4.93M 10-K · filed 2022-03-10 |
| 2020-09-30 | $5.67M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $4.26M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $3.83M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.64M 10-K · filed 2021-03-11 |
| 2019-09-30 | $3.41M 10-Q · filed 2019-12-11 |
| 2018-12-31 | $2.49M 10-K · filed 2020-03-30 |